Skip to main content

Table 1 Antimicrobial resistance patterns of Gram-negative bacterial pathogenic strains isolated from burn patients

From: Detection of carbapenemases blaOXA48-blaKPC-blaNDM-blaVIM and extended-spectrum-β-lactamase blaOXA1-blaSHV-blaTEM genes in Gram-negative bacterial isolates from ICU burns patients

Antibiotics Antimicrobial resistant isolates n = 104 (%)
Pseudomonas Klebsiella Acinetobacter Proteus Others Total
β-lactamas   
 Aztreonam (ATM) 50 (48.1) 19 (18.3) 13 (12.5) 10 (9.6) 12 (11.5) 104 (100)
 Piperacillin (PIP) 48 (46.2) 18 (17.3) 13 (12.5) 10 (9.6) 11 (10.6) 100 (96.2)
 Piperacillin-tazobactam (TZP) 40 (38.5) 14 (13.5) 10 (9.6) 9 (8.7) 7 (6.7) 80 (76.9)
 Amoxycillin-clavulanate (AMC) 46 (44.2) 14 (13.5) 12 (11.5) 7 (6.7) 10 (9.6) 89 (85.6)
Cephalosporins   
 Cefotaxime (CTX) 19 (18.3) 10 (9.6) 12 (11.5) 104 (100)
 Ceftazidime (CAZ) 50 (48.1) 19 (18.3) 13 (12.5) 10 (9.6) 12 (11.5) 104 (100)
 Cefepime (FEP) 45 (43.3) 18 (17.3) 12 (11.5) 9 (8.7) 12 (11.5) 96 (92.3)
Carbapenems   
 Doripenem (DOR) 31 (29.8) 11 (10.6) 5 (4.8) 4 (3.8) 8 (7.7) 59 (56.7)
 Imipenem (IMI) 28 (26.9) 12 (11.5) 4 (3.8) 5 (4.8) 11 (10.6) 60 (57.7)
 Meropenem (MEM) 32 (30.7) 11 (10.6) 5 (4.8) 4 (3.8) 9 (8.7) 61 (58.7)
Aminoglycosides   
 Amikacin (AMK) 50 (48.1) 19 (18.3) 13 (12.5) 10 (9.6) 12 (11.5) 104 (100)
 Gentamicin (GEN) 41 (39.4) 17 (16.4) 13 (12.5) 9 (8.7) 11 (10.6) 91 (87.5)
 Tobramycin (TOB) 40 (38.5) 18 (17.3) 12 (11.5) 8 (7.7) 12 (11.5) 90 (86.5)
Quinolones   
 Ciprofloxacin (CIP) 40 (38.5) 18 (17.3) 11 (10.6) 10 (9.6) 8 (7.7) 87 (83.7)
 Levofloxacin (LEV) 42 (40.4) 16 (15.4) 13 (12.5) 9 (8.7) 9 (8.7) 89 (85.6)
  1. Only mentioned resistance %